Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Conditions

• Breast Cancer
• Breast Cancer Stage II
• Breast Cancer Stage III
• Breast Cancer Invasive
• Breast Cancer Triple Negative

Interventions

• RADIATION: Radiation
• DRUG: Pembrolizumab (KEYTRUDA®)

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's